Spirochaetal lipoproteins and pathogenesis.
Haake
David A
DA
Division of Infectious Diseases, 111F, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, CA 90073, USA and Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90095, USA1.
D000222:Adaptation, Physiological; D000818:Animals; D000940:Antigenic Variation / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology / Q000378:metabolism; D001425:Bacterial Outer Membrane Proteins / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D004926:Escherichia coli / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D008074:Lipoproteins / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D013142:Spirochaeta / Q000737:chemistry / Q000472:pathogenicity*; D013143:Spirochaetaceae / Q000472:pathogenicity; D013145:Spirochaetales Infections / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D008074:Lipoproteins; D014614:Vaccines, Synthetic